Skip To Main Content
Barbara Bell on Muck Rack

Barbara Bell

As seen in: Medical Journal of Australia (MJA), International Tax Review
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Barbara

Contact Barbara, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Summary of the CBAM regulation: what this could mean for your business

|
By Warwick Ryan, Christopher Ll Morgan, Barbara Bell
| International Tax Review Verified
Regulation of the European Parliament and of the Council establishing a carbon border adjustment mechanism Carbon border adjustment mechanism (CBAM) reporting obligations commence from October 1 2023, meaning it is urgent for importers to the EU, and EU companies producing or importing goods with high embedded emissions, to prepare for these developments.
Open in Who Shared Issue with article?

Green light for the renewable energy and energy efficiency directives

|
By Barbara Bell, Ruth Guerra, Mike Hayes Verified, Loek Helderman, Chris Morgan, Merijn Betjes, Nicole De Jager, Warwick Ryan
| International Tax Review Verified
The EU is forging ahead with its plans to make Europe the first climate-neutral continent by 2050, after the European Parliament voted on the energy efficiency and renewable energy directives on September 14 2022.
Open in Who Shared Issue with article?

Fifty years of RhD immunoglobulin (anti-D) therapy in Australia: celebrating a public health success story

|
By Janet Wong, Amanda Thomson, Barbara Bell, James Thyer
| Medical Journal of Australia (MJA) Verified
In 2017, Australia celebrated the 50th anniversary of the anti-D program, which uses the plasma of special donors to protect the babies of millions of Australian women At the 11th Congress of the International Society of Blood Transfusion held in Sydney in 1966, researchers from Liverpool1 and New York2 announced the first successful trials of Rhesus (Rh) D immunoglobulin (Ig) — or anti-D — derived from human plasma to prevent the effects of RhD blood group incompatibility between an...
Open in Who Shared Issue with article?
See all 4 articles